PRESS RELEASES

All Releases
Apr 10, 2002
Pain Therapeutics to Present at Two Investor Conferences SOUTH SAN FRANCISCO, Calif., April 10 -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a medical research company, today announced that management will present at two investor conferences. The Company presentation will be given at the Thomas Weisel
Apr 04, 2002
Pain Therapeutics Expands Patent Portfolio for Novel Pain Medications SOUTH SAN FRANCISCO, Calif., Apr 4, 2002 /PRNewswire via COMTEX/ -- Pain Therapeutics, Inc., (Nasdaq: PTIE), a medical research company, today announced a significant expansion of its patent portfolio.
Mar 15, 2002
New Data Shows Lack of Drug Tolerance or Dependence With Novel Opioid Painkillers SOUTH SAN FRANCISCO, Calif., Mar 15, 2002 -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a medical research company, today presented new data on its two novel opioid painkillers, OxyTrex(TM) and MorViva(TM), at the 21st
Mar 07, 2002
Pain Therapeutics to Present New Data at the American Pain Society Meeting SOUTH SAN FRANCISCO, Calif., Mar 7, 2002 -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a medical research company, today announced that it will present new data at the 21st Annual Scientific Meeting of the American Pain Society
Feb 22, 2002
Pain Therapeutics Appoints New Board Member and Announces Brand Names SOUTH SAN FRANCISCO, Calif., Feb. 22 -- Pain Therapeutics, Inc., (Nasdaq: PTIE), a medical research company, today announced it has added a new member to its Board of Directors. Effective immediately, Richard Stevens will join
Dec 11, 2001
Pain Therapeutics Announces Positive Phase I/II Clinical Results With Novel Painkiller SOUTH SAN FRANCISCO, Calif., Dec. 11 -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a medical research company, today announced positive Phase I/II results with PTI-801, a novel narcotic painkiller.
Nov 02, 2001
Pain Therapeutics to Present at CIBC World Markets Health Care Conference SOUTH SAN FRANCISCO, Calif., Nov 2, 2001 -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a drug development company, today announced that Remi Barbier, Pain Therapeutics' president and chief executive officer is scheduled to
Oct 31, 2001
Pain Therapeutics Appoints Nadav Friedmann, M.D., Ph.D., Chief Operating Officer SOUTH SAN FRANCISCO, Calif., Oct 31, 2001 -- Clinical Team Expanded to Accelerate Drug Research and Development Programs Pain Therapeutics, Inc. (Nasdaq: PTIE), a drug development company, today announced the
Oct 09, 2001
Pain Therapeutics to Present at UBS Warburg Global Life Science Conference SOUTH SAN FRANCISCO, Calif., Oct 9, 2001 -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a drug development company, today announced that Remi Barbier, Pain Therapeutics' president and chief executive officer is scheduled to